A German follow-up long-term observation over 2 years in patients who had previously completed a clinical study to evaluate the effectiveness and safety of the TNF-alpha antibody infliximab in the treatment of patients with rheumatoid arthritis

被引：0
|
作者：
Kalden, JR
Soerensen, H
Haentzschel, H
机构：
[1] Univ Erlangen Nurnberg, Med Klin 3, D-8520 Erlangen, Germany
[2] Immanuel Krankenhaus, Berlin, Germany
[3] Univ Leipzig, Med Klin & Poliklin 4, D-7010 Leipzig, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [41] Clinical and radiographic findings in a long-term follow-up study of psoriatic arthritis suggest that patients with type-2 psoriasis and female gender have a milder disease phenotype
    Haroon, M.
    Gallagher, P.
    FitzGerald, O.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S112 - S112
  • [42] Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up
    Langley, R. G.
    Lebwohl, M.
    Krueger, G. G.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Hsu, M. C.
    You, Y.
    Poulin, Y.
    Korman, N.
    Prinz, J. C.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) : 1371 - 1383
  • [43] Long-term maintenance of coronary flow reserve improvement in type 2 diabetes patients after dapagliflozin treatment: results from the 4-years DAPAHEART follow-up study
    Morciano, C.
    Cinti, F.
    Sorice, G.
    Leccisotti, L.
    Gugliandolo, S.
    Capece, U.
    Cappannoli, L.
    D'Amario, D.
    Di Giuseppe, G.
    Mezza, T.
    Ciccarelli, G.
    Soldovieri, L.
    Crea, F.
    Giordano, A.
    Giaccari, A.
    DIABETOLOGIA, 2024, 67 : S342 - S342
  • [44] Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial
    Garcia-Olmo, Damian
    Gilaberte, Inmaculada
    Binek, Matthias
    Hoore, Andre J. L. D.
    Lindner, Dirk
    Selvaggi, Francesco
    Spinelli, Antonino
    Panes, Julian
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 713 - 720
  • [45] Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission - Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke
    Ejbjerg, Bo
    Hetland, Merete L.
    Moeller, Jakob
    Christensen, Robin
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne Merete
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3701 - 3703
  • [46] Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a-one-year placebo-controlled study and participated in a two-year follow-up study
    Winblad, B
    Engedal, K
    Soininen, H
    Verhey, FRJ
    Waldemar, G
    Wimo, A
    Wetterholm, AL
    Haglund, A
    Zhang, R
    Burger, L
    Schindler, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S402 - S403
  • [47] Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study
    Winblad, B
    Engedal, K
    Soininen, H
    Verhey, F
    Waldemar, G
    Wimo, A
    Wetterholm, AL
    Zhang, R
    Burger, L
    Schindler, R
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 292 - 293
  • [48] Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke Midtboll
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Christensen, Robin
    Ostergaard, Mikkel
    RMD OPEN, 2024, 10 (01):
  • [49] Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Mease, Philip J.
    Krueger, Gerald G.
    Gladman, Dafna D.
    van der Heijde, Desiree
    Mudivarthy, Surekha
    Xu, Weichun
    Mack, Michael
    Xu, Zhenhua
    Beutler, Anna
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1777 - 1785
  • [50] Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Glinatsi, Daniel
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Christensen, Robin
    Nielsen, Sabrina Mai
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne Merete
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1758 - 1760
12345